Wave Life Sciences (WVE) Earnings Analysis

Wave Life Sciences (WVE) next reports earnings on 2026-07-30, consensus EPS -0.31 USD. Last quarter (2026-02-26) it missed with EPS -0.3 USD vs -0.28 USD est (-7.1%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -5.42.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does WVE next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate-0.31 USD
Revenue estimate0.01B

WVE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-26-0.3 USD-0.28 USD-7.1%Miss
2025-11-10-0.32 USD-0.3 USD-6.7%Miss
2025-05-08-0.29 USD-0.27 USD-7.4%Miss
2025-03-040.17 USD-0.17 USD+200%Beat
2024-08-08-0.25 USD-0.21 USD-19%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

WVE valuation and analyst view

Trailing P/E-5.42
Trailing EPS-0.91717 USD
Price / book2.25
Dividend yield0.00%
Market cap1.09B
Analyst consensusBuy (24 buy / 1 hold / 0 sell)
Avg price target13.75 USD

Related research pages

Frequently asked questions

When is Wave Life Sciences (WVE)'s next earnings date?

Wave Life Sciences is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.31 USD and revenue estimate of 0.01B.

Did WVE beat earnings last quarter?

In its 2026-02-26 report, WVE posted EPS of -0.3 USD versus a -0.28 USD estimate — a miss of 7.1%.

What is WVE's earnings track record?

Over the last 5 reported quarters with consensus data, WVE beat estimates 1 times (20%).

What is WVE's current P/E ratio and EPS?

WVE trades at a trailing P/E of -5.42 on trailing EPS of -0.9171651819903224 USD.

What do analysts rate WVE?

Analyst consensus is "Buy" across 25 ratings (1 strong buy, 23 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 13.75 USD.